Since the discovery of SMN1-causing phenotypes in SMA two decades ago [73], many researchers have highlighted SMN2 regulation as a rational approach to boost the generation of full-length SMN2 to offset disease effects [18, 22]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.